Back to search

France· FR:66830922

URSOLVAN 200 mg, gélule

A medicinal product containing ursodésoxycholique (acide), registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedURSOLVAN 200 mg, géluleATC—REGISTER NO.FR:66830922PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
URSODÉSOXYCHOLIQUE (ACIDE)
Manufacturer
CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932340750
    plaquette(s) thermoformée(s) PVC-aluminium de 30 gélule(s)
    EUR 8.76

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ursodésoxycholique (acide) in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ursodésoxycholique (acide) products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ursodeoxycholsäure Pharmaceutical Innovation, Ursofalk
  • Belgium · Dozurso, Ursochol
  • Bulgaria · Proursan, Udca 250 Mg
  • Cyprus · Ursobil, Ursofalk
  • Czechia · Udihep, Ursofalk
  • Germany · Urso, Ursochol
  • Denmark · Ursedeoxycholsyre Orion, Ursochol
  • Estonia · Ursogrix, Ursosan
  • Spain · Adisocol, Colefel
  • Finland · Ursochol, Ursosan
  • United Kingdom (Northern Ireland) · Cholurso, Deoxxa
  • Greece · Ursodeoxycholic Acid Pharmaceutical Innovation, Ursofalk
  • Croatia · Udihep, Ursofalk
  • Hungary · Dozurso, Proursan
  • Ireland · Cholurso, Proursan
  • Iceland · Ursochol
  • Italy · Acido Ursodesossicolico Abc, Acido Ursodesossicolico Aurobindo
  • Lithuania · Ursofalk, Ursogrix
  • Luxembourg · Ursochol, Ursodeoxycholic Acid Amdipharm
  • Latvia · Ursofalk, Ursogrix
  • Malta · Ursobil, Ursodeoxycholic Acid Aurobindo
  • Netherlands · Grinterol, Ursochol
  • Norway · Ursochol, Ursodeoxycholic Acid Orion
  • Poland · Aurourso, Kwas Ursodeoksycholowy Pharmaceutical Innovation
  • Portugal · Ácido Ursodesoxicólico Generis, Grinterol
  • Romania · Ursofalk, Ursogrix
  • Sweden · Ursodeoxycholic Acid Orion, Ursofalk
  • Slovenia · Ursofalk
  • Slovakia · Ursofalk, Ursogrix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3ab7ced-1b2c-4b0f-b93b-4fea91f2872e
GET /v1/drugs/e3ab7ced-1b2c-4b0f-b93b-4fea91f2872e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66830922",
  "date_amm": "1980-05-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "URSODÉSOXYCHOLIQUE (ACIDE)",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ursodésoxycholique (acide).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.